Boston Celtics Chemistry Issues Could Derail 2011-12 NBA Season Before It Starts

There were six players under contract for the entirety of the NBA lockout, and now the Celtics are a team with a full roster.

As a result, the Celtics are a newly assembled team with little time to build an understanding with one another on and off the court.

The opening move for the Boston Celtics was a controversial one, as Danny Ainge and the organization looked to trade Rajon Rondo in exchange for the New Orleans Hornets All-Star point guard Chris Paul.

Shopping Rondo, an All-Star point guard moving up in the ranks as a league-elite at his position, is a move that seemed out of desperation and lacked substance.

The team would have had to trade another player, more than likely forward Glen Davis, along with Rondo for CP3, as well as draft picks.

Not to mention, Paul only planned to play with the team one season if he was to join according to Yahoo! Sports, as it was evident CP3 has no interest in becoming a Celtic.

Chris Paul brings the Celtics championship hopes in the one year he would be with the team.

Last season, Paul posted 15.8 points, 9.8 assists and 4.1 rebounds in the regular season.

Yet what makes a potential CP3 trade problematic is it takes a significant hit on the future rebuilding of the Boston Celtics post-Big Three and if the trade didn't happen, Rondo's confidence would take a hit.

Rondo is one of the leaders of this Celtics team as well as a leader in the future of the team—all of these trade rumors essentially tell Rondo he is not good enough to build around in the future.

Rondo is not only a league-elite, but until late in the season last year, was the league's assist leader. His 11.2 assists per game were a career high and second only to point guard Steve Nash. Talk about some solid numbers.

Although CP3 may have been able to help the team's chances this season—which is still questionable—what would be essentially renting Chris Paul for a year is not a move worth the risk with Rondo guaranteed to be a starting point guard in the league for a good eight-to-10 seasons.

After focusing their attention on acquiring Chris Paul for the first week of the free-agency period, the Celtics now enter the season with a completely new, inexperienced rotation, and a point guard that knows he doesn't have the full confidence of the organization.

With Jeff Green going down for the season with a surgery to repair an aortic aneurysm, the team is all the more hurt talent-wise and loses a player that played with the team last season and understands his role in the system—which further hurts this team's chemistry.

There is no doubt the Celtics have the talent to get it done, yet their fluidity and cohesiveness as a unit on the court might take several shots after poor offseason management as an organization and unfortunate circumstances with Jeff Green's surgery.

It will be essential for the Big Three to hold together the team's composure and help lead the team to a strong season with their top-notch play. Paul Pierce, Kevin Garnett and Ray Allen are all hoping to give it one last shot, and understand team chemistry will be a must going forward.